Reuters logo
BRIEF-Corline Biomedical applies for Orphan Drug status for Renaparin at FDA
November 3, 2015 / 9:47 AM / 2 years ago

BRIEF-Corline Biomedical applies for Orphan Drug status for Renaparin at FDA

Nov 3 (Reuters) - Corline Biomedical AB :

* Applies for Orphan Drug status for Renaparin at U.S. Food and Drug Administration (FDA) Source text for Eikon:

Further company coverage: (Gdynia Newsroom)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below